Compare Stocks

→ Nvidia Has a BIG Problem — Here’s Who Benefits MOST (From Weiss Ratings) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLU BELLUS Health	$14.74	$14.62	$6.38 ▼ $14.76	$1.87B	0.19	3.08 million shs	3.45 million shs
BUL Pacer US Cash Cows Growth ETF	$40.20	$40.60	$32.36 ▼ $42.72	$46.23M	0.89	6,836 shs	846 shs
CDH Corridor Resources		C$1.38	C$0.62 ▼ C$1.48	C$121.64M	N/A	528,295 shs	103,002 shs
GEV GE Vernova	$137.22 +1.8%	$0.00	$115.00 ▼ $152.48	$37.33B	N/A	7.95 million shs	4.80 million shs

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLU BELLUS Health	0.00%	0.00%	0.00%	0.00%	+2.08%
BUL Pacer US Cash Cows Growth ETF	-1.08%	-2.88%	-1.37%	+11.51%	+12.83%
CDH Corridor Resources	0.00%	0.00%	0.00%	0.00%	0.00%
GEV GE Vernova	+3.58%	-2.56%	+13,469,999,900.00%	+13,469,999,900.00%	+13,469,999,900.00%

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BLU BELLUS Health	0.0624 of 5 stars	1.0	0.0	0.0	0.0	0.6	3.3	0.0
BUL Pacer US Cash Cows Growth ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CDH Corridor Resources	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GEV GE Vernova	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLU BELLUS Health	2.00	Hold	$14.75	0.07% Upside
BUL Pacer US Cash Cows Growth ETF	0.00	N/A	$42.82	6.52% Upside
CDH Corridor Resources	N/A	N/A	N/A	N/A
GEV GE Vernova	3.00	Buy	$160.00	16.60% Upside

Current Analyst Ratings

Latest IGAS, GEV, CDH, BUL, and BLU Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/18/2024	GEV GE Vernova	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$174.00
4/17/2024	GEV GE Vernova	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$177.00
4/17/2024	GEV GE Vernova	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$160.00
4/16/2024	GEV GE Vernova	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$154.00
4/15/2024	GEV GE Vernova	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$154.00
4/12/2024	GEV GE Vernova	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$160.00
4/8/2024	GEV GE Vernova	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$141.00
4/2/2024	GEV GE Vernova	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral ➝ Neutral	$141.00
4/2/2024	GEV GE Vernova	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$160.00

(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLU BELLUS Health	$15K	124,613.93	N/A	N/A	$3.09 per share	4.77
BUL Pacer US Cash Cows Growth ETF	N/A	N/A	N/A	N/A	N/A	N/A
CDH Corridor Resources	C$10.27M	0.00	N/A	1.44	C$1.28 per share	0.00
GEV GE Vernova	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLU BELLUS Health	-$76.08M	-$0.72	N/A	N/A	N/A	-578,586.63%	-24.27%	-23.14%	N/A
BUL Pacer US Cash Cows Growth ETF	N/A	N/A	9.14	∞	N/A	N/A	N/A	N/A	N/A
CDH Corridor Resources	N/A	C$0.08	16.63	N/A	N/A	N/A	N/A	N/A	N/A
GEV GE Vernova	N/A	N/A	0.00	43.15	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLU BELLUS Health	N/A	N/A	N/A	N/A	N/A
BUL Pacer US Cash Cows Growth ETF	$0.24	0.60%	N/A	N/A	N/A
CDH Corridor Resources	N/A	N/A	N/A	N/A	N/A
GEV GE Vernova	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLU BELLUS Health	N/A	33.42	33.42
BUL Pacer US Cash Cows Growth ETF	N/A	N/A	N/A
CDH Corridor Resources	0.28	69.35	67.53
GEV GE Vernova	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
BLU BELLUS Health	90.37%
BUL Pacer US Cash Cows Growth ETF	N/A
CDH Corridor Resources	N/A
GEV GE Vernova	N/A

Insider Ownership

Company	Insider Ownership
BLU BELLUS Health	24.17%
BUL Pacer US Cash Cows Growth ETF	N/A
CDH Corridor Resources	N/A
GEV GE Vernova	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BLU BELLUS Health	74	126.81 million	96.16 million	Not Optionable
BUL Pacer US Cash Cows Growth ETF	N/A	1.15 million	N/A	Not Optionable
CDH Corridor Resources	11	88.15 million	N/A	Not Optionable
GEV GE Vernova	80,000	272.06 million	N/A	N/A

IGAS, GEV, CDH, BUL, and BLU Headlines

Source	Headline
	Wall Street's Earnings Blunders: Don't Miss These 3 Mispriced Plays investorplace.com - April 18 at 4:00 PM
	Goldman Sachs' first verdict on GE Vernova: 'uniquely positioned' rechargenews.com - April 18 at 12:56 PM
	GE Vernova (NYSE:GEV) Coverage Initiated by Analysts at Evercore ISI marketbeat.com - April 18 at 8:16 AM
	GE Vernova to Announce First Quarter 2024 Financial Results on April 25 businesswire.com - April 18 at 8:00 AM
	GE Vernova announces strategic initiatives with the Republic of Iraq to further strengthen the power sector zawya.com - April 18 at 7:55 AM
	GE Vernova rises on Outperform rating from Raymond James finance.yahoo.com - April 17 at 8:46 PM
	GE Vernova (NYSE:GEV) Given Consensus Rating of "Buy" by Brokerages marketbeat.com - April 17 at 4:26 PM
	GE Vernova (NYSE:GEV) Coverage Initiated at BNP Paribas marketbeat.com - April 17 at 3:51 PM
	GE Vernova LLC (GEV) uk.investing.com - April 17 at 3:45 PM
	Analysts Bullish on GE Vernova Following GE’s Three-Way Split tokenist.com - April 17 at 3:45 PM
	A New Buy Rating Pushes Up GE Vernova Stock, Finally barrons.com - April 17 at 1:01 PM
	GE Vernova (NYSE:GEV) Now Covered by Analysts at The Goldman Sachs Group americanbankingnews.com - April 17 at 4:30 AM
	Goldman Sachs Thinks GE Vernova Is Uniquely Positioned To Electrify And Decarbonize Future markets.businessinsider.com - April 16 at 6:32 PM
	GE Vernova started as Buy at Goldman Sachs, set for boost from energy transition msn.com - April 16 at 6:32 PM
	Goldman Sachs sees GE Vernova as a buy, sets $154 target za.investing.com - April 16 at 1:25 PM
	GE Vernova Inc GEV morningstar.com - April 16 at 7:43 AM
	GE Vernova (NYSE:GEV) Now Covered by Analysts at Mizuho americanbankingnews.com - April 16 at 4:46 AM
	GE Vernova (NYSE:GEV) Lands Buy Rating from Mizuho Securities msn.com - April 15 at 9:12 PM
	What's Going On With GE Vernova Shares Today? markets.businessinsider.com - April 15 at 4:11 PM
	GE's Historic Crotonville Academy Reportedly Sold: End Of An Era? msn.com - April 15 at 9:57 AM
	GE Vernova's (GEV) "Outperform" Rating Reaffirmed at Royal Bank of Canada americanbankingnews.com - April 14 at 3:58 AM
	GE Vernova completes spin-off, starts trading on NY bourse tradearabia.com - April 13 at 3:05 PM
	Ge Vernova (NYSE: GEV) fool.com - April 12 at 6:49 PM
	Royal Bank of Canada Reiterates "Outperform" Rating for GE Vernova (NYSE:GEV) marketbeat.com - April 12 at 11:20 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

5 Stocks in the Current Bull Market with Upside to Come
April 5, 2024 10:14 AM
View 5 Stocks in the Current Bull Market with Upside to Come
Bargain Alert: AMD is on the Verge of a Massive Catchup Play
April 4, 2024 8:56 AM
View Bargain Alert: AMD is on the Verge of a Massive Catchup Play
Analysts are Bullish on These 4 Oversold Large Cap Stocks
April 1, 2024 11:37 AM
View Analysts are Bullish on These 4 Oversold Large Cap Stocks
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
March 27, 2024 7:30 AM
View Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
The Most Bought AI Stock by Congress Isn’t NVIDIA
March 27, 2024 7:00 AM
View The Most Bought AI Stock by Congress Isn’t NVIDIA

All Headlines

Company Descriptions

BELLUS Health

NASDAQ:BLU

BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.

Pacer US Cash Cows Growth ETF

NYSEARCA:BUL

The Pacer US Cash Cows Growth ETF (BUL) is an exchange-traded fund that is based on the Pacer US Cash Cows Growth index. The fund tracks a market cap-weighted index of large- and mid-cap US growth equities selected using fundamental factors. BUL was launched on May 2, 2019 and is managed by Pacer.

Corridor Resources

TSE:CDH

Corridor Resources Inc., a junior resource company, explores for, develops, and produces petroleum and natural gas. The company explores for petroleum and natural gas onshore in New Brunswick and Québec; and offshore in the Gulf of St. Lawrence. Its principal properties include the McCully Field located to the northeast of Sussex, New Brunswick; the Frederick Brook Shale located in the Elgin sub-basin in southern New Brunswick; and the Old Harry prospect located in the Gulf of St. Lawrence. As at December 31, 2017, the company had an interest in 38 net producing and nonproducing natural gas and oil wells. Corridor Resources Inc. was founded in 1983 and is headquartered in Halifax, Canada.

GE Vernova

NYSE:GEV

GE Vernova LLC, an energy business company, generates electricity. It operates under three segments: Power, Wind, and Electrification. The Power segments generates and sells electricity through hydro, gas, nuclear, and steam power. Wind segment engages in the manufacturing and sale of wind turbine blades; and Electrification segment provides grid solutions, power conversion, solar, and storage solutions. The company was incorporated in 2023 and is based in Cambridge, Massachusetts. GE Vernova operates as a subsidiary of General Electric Company.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial